Abstract
Objective: To evaluate the impact of the National Cholesterol Educational Program Adult Treatment Panel III (ATP III) and the Framingham Offspring Study on Omani diabetic subjects. Methods: 221 subjects with type 2 diabetes (86 females and 135 males) and 156 non-diabetic subjects (70 females and 86 males) aged 30-70 years attending Sultan Qaboos University Hospital between 1999-2002 were recruited. Lipid profile, glucose, %HbA1c, apoprotein A-1 and apoproteinB were measured. Low density lipoprotein was calculated using the Friedwald formula. ATP-III and Framingham Offspring Study guidelines were used to classify lipid parameters into coronary heart disease-risk categories. Results: Diabetic compared to non-diabetic subjects had significantly higher triglycerides of >1.7 mmol/L (p=0.01) and lower low density lipoprotein cholesterol of >4.2 mmol/L (p=0.012 ) and, in female subjects only, lower high density lipoprotein cholesterol of <0.05 mmo/L for ( p<0.0001). In addition, 57% of diabetic subjects had abnormal aplipoproteinB of >1.2 g/L compared to 49% of non-diabetic subjects. Combined raised levels of triglycerides, apolipoproteinB and low levels of high density lipoprotein were found in 42% of diabetic compared to 26% of the non-diabetic subjects (p=0.05). Diabetic subjects had significantly higher (p=0.008) NCEP risk-score for coronary artery disease, however, only 34% conformed to a NCEP 10-year-risk score of >10%. Conclusion: A substantial proportion of the Omani diabetic subjects were dyslipidaemic according to the ATP III guidelines. This study recommends the implementation of a lower cut-off threshold for starting lipid-modifying agents for Omani diabetics when using the 10-year Framingham Risk Scoring equation.
Publication details
- DOI
- 10.18295/2075-0528.2622
- Journal
- Sultan Qaboos University Medical Journal, 6(2), 19-25
- Publisher
- Sultan Qaboos University
- Open access
- Gold open access
- License
- CC BY-ND 4.0
Cite this article
APA 7
Al-Bahrani, A. I., Bayoumi, R., & A., S. (2025). Lipids-Risk Categories in Omani Type 2 Diabetics: Impact of the National Cholesterol Educational Program. Sultan Qaboos University Medical Journal, 6(2), 19-25. https://doi.org/10.18295/2075-0528.2622
MLA 9
Al-Bahrani, Ali I., et al. "Lipids-Risk Categories in Omani Type 2 Diabetics: Impact of the National Cholesterol Educational Program." Sultan Qaboos University Medical Journal, vol. 6, no. 2, 2025, pp. 19-25. https://doi.org/10.18295/2075-0528.2622.
Chicago (author–date)
Al-Bahrani, Ali I., Riad Bayoumi, and Said A. 2025. "Lipids-Risk Categories in Omani Type 2 Diabetics: Impact of the National Cholesterol Educational Program." Sultan Qaboos University Medical Journal 6 (2): 19-25. https://doi.org/10.18295/2075-0528.2622.
Harvard
Al-Bahrani, A. I., Bayoumi, R. and A., S. (2025) 'Lipids-Risk Categories in Omani Type 2 Diabetics: Impact of the National Cholesterol Educational Program', Sultan Qaboos University Medical Journal, 6(2), pp. 19-25. doi:10.18295/2075-0528.2622.
Vancouver
Al-Bahrani AI, Bayoumi R, A. S. Lipids-Risk Categories in Omani Type 2 Diabetics: Impact of the National Cholesterol Educational Program. Sultan Qaboos University Medical Journal. 2025;6(2):19-25. doi:10.18295/2075-0528.2622
IEEE
A. I. Al-Bahrani, R. Bayoumi, and S. A., "Lipids-Risk Categories in Omani Type 2 Diabetics: Impact of the National Cholesterol Educational Program," Sultan Qaboos University Medical Journal, vol. 6, no. 2, pp. 19-25, 2025, doi: 10.18295/2075-0528.2622.